Elicio Therapeutics, Inc. (ELTX)

NASDAQ: ELTX · IEX Real-Time Price · USD

3.390

-0.390 (-10.32%)

At close: Jul 2, 2024, 4:00 PM

3.580

+0.190 (5.60%)

After-hours: Jul 2, 2024, 5:20 PM EDT

Elicio Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	35	70	24	87	-	-
Market Cap Growth	345.37%	186.88%	-71.87%	-	-	-
Enterprise Value	29	63	24	3	22	5
PE Ratio	-	-1.99	-0.87	-1.59	-	-
PS Ratio	-	-	-	3.07	-	-
PB Ratio	7.15	6.17	-0.24	1.07	-	-
P/FCF Ratio	-2.12	-2.14	-1.07	-1.64	-	-
P/OCF Ratio	-2.12	-2.14	-1.10	-1.65	-	-
EV/Sales Ratio	-	-	-	0.10	7.61	3.50
EV/EBITDA Ratio	-1.95	-1.92	-1.02	-0.05	-0.31	-0.13
EV/EBIT Ratio	-1.88	-1.86	-0.98	-0.05	-0.31	-0.13
EV/FCF Ratio	-1.96	-1.94	-1.06	-0.05	-0.96	-0.21
Debt / Equity Ratio	1.37	0.61	-0.07	0.06	-0.62	-0.58
Debt / EBITDA Ratio	-0.18	-0.21	-0.32	-0.09	-0.80	-0.27
Debt / FCF Ratio	-0.18	-0.21	-0.33	-0.09	-2.47	-0.43
Quick Ratio	2.10	1.40	1.14	7.93	0.32	0.23
Current Ratio	2.37	1.68	1.56	8.08	0.39	0.23
Asset Turnover	0	0	0	0.24	0.10	0.08
Interest Coverage	-50.78	-32.23	-6.84	-28.55	-8.06	-
Return on Equity (ROE)	-293.80%	-160.20%	-150.40%	-69.20%	146.90%	-25020.30%
Return on Assets (ROA)	-129.70%	-102.40%	-47.80%	-46.30%	-270.50%	-211.10%
Return on Capital (ROIC)	-330.80%	-195.43%	25.07%	-45.62%	162.92%	494.25%
Earnings Yield	-112.00%	-50.20%	-115.42%	-62.82%	-	-
FCF Yield	-105.60%	-46.67%	-93.42%	-61.04%	-	-
Buyback Yield / Dilution	-3069.93%	-1500.08%	88.81%	-91.33%	-2.26%	-49.03%
Total Shareholder Return	-3069.93%	-1500.08%	88.81%	-91.33%	-2.26%	-49.03%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).